Dynavax Technologies Corp Headquarters
Looking for information about Dynavax Technologies Corp Headquarters? The links below have collected all the necessary data.
https://www.crunchbase.com/organization/dynavax-technologies
Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18Founded: 1996
https://finance.yahoo.com/quote/DVAX/profile
Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Corporate Governance Dynavax Technologies Corporation’s ISS Governance QualityScore as ...
https://www.linkedin.com/company/dynavax-technologies
Dynavax Technologies 10,557 followers on LinkedIn. Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company …
https://www.bloomberg.com/profile/company/DVAX:US
Dynavax Technologies Corp. Dynavax Technologies Corporation discovers, develops, and seeking to commercialize products based on immunostimulatory sequences. The Company developes products to …Employees: 245
https://www.linkedin.com/company/dynavax-gmbh
Dynavax GmbH is the European affiliate of Dynavax Technologies Corporation USA, located in Düsseldorf, Germany. For more than 25 years, we have been dedicated to …
https://www.glassdoor.com/Overview/Working-at-Dynavax-Technologies-EI_IE12958.11,31.htm
Glassdoor gives you an inside look at what it's like to work at Dynavax Technologies, including salaries, reviews, office photos, and more. This is the Dynavax Technologies company profile. All content is posted anonymously by employees working at Dynavax Technologies.
https://robinhood.com/stocks/DVAX
About DVAX. Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. CEO.
https://www.glassdoor.com/Photos/Dynavax-Technologies-Office-Photos-E12958.htm
( BERKELEY, CA -- (Marketwired) -- 01/07/16 -- Dynavax Technologies Corporation NASDAQ: DVAX) today reported preliminary top-line results from HBV-23, a Phase 3 trial of the safety and immunogenicity of its investigational hepatitis B vaccine, HEPLISAV-B, compared with a currently marketed vaccine, Engerix-B , in adults 18 to 70 years of age.
https://seekingalpha.com/filing/4877687
Dynavax Technologies Corporation was incorporated in California in August 1996 under the name Double Helix Corporation, and we changed our name to Dynavax Technologies Corporation in September 1996.
Have you found Dynavax Technologies Corp Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|